Healthcare Roundup – European regulators on board with Mylan/Upjohn tie-up, BioCryst feels Gilead’s remdesivir pain Life Science
Technology Roundup – Risk is limited in Facebook’s Jio stake, Intel lower after soft EPS outlook Technology
Healthcare Roundup – FDA OKs Immunomedics antibody-drug conjugate for breast cancer, Pfizer and BioNTech on go with COVID-19 vaccine study Life Science
Technology Roundup – Apple will add $75-100M in buybacks, Cleveland Research sees Q2 strength for Micron Technology
Healthcare Roundup – Liberty Health Sciences updates business amid COVID-19, Atyr Pharma on go with study of lead drug in COVID-19 Life Science
Technology Roundup – Apple wants to boost iPhone production, Amazon has path to $4,000/share Technology
Healthcare Roundup – Another U.S. study points to far higher rate of COVID infection, Money flow spikes in COVID-19 vaccine players amid rush for early data Life Science
Technology Roundup – Nokia, U.S. Cellular boosting capacity in virus-affected markets, Micron Waste to acquire Canadian COVID-19 equipment manufacturer Technology
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 Life Science
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit Life Science
A Closer Look at Mining Investment – Three Month Review Since Our GCFF Resource Investment Conference Base Metals, Precious Metals
Healthcare Roundup – U.S. COVID-19 testing capacity still constrained, Sanofi can produce up to 600M doses of COVID-19 vaccine Life Science
Technology Roundup – Facebook cancels large gatherings, Cloud customers can’t make a deal with Amazon Life Science
